Mount Carmel, Israel
Description: Check-Cap Ltd. is a clinical-stage medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the screening for colorectal cancer (CRC). The company’s imaging capsule is designed to ingest without any cleansing of the colon and to travel through the gastrointestinal tract naturally. The company’s imaging capsule consists of an X-ray source and several X-ray detectors. The company’s imaging capsule is designed to create a reconstructed three-dimensional (3D) image of the colon and to enable detection of clinically polyps. The company has also designed a Capsule Positioning System (CPS) for a complete view of capsule positioning and motility, which is mounted on the patient’s back throughout the entire procedure. The CPS is designed to provide the physician with localization data aligned with a reconstructed image.
Competition: Given Imaging Ltd, Olympus Corp.
Exchange and Ticker: Nasdaq: CHEKU
Filing Range: 2M shares @ $6.00 to $8.00
Date of IPO: 2/19/15
Offering Price: $6.00
Offering Size: $12M
Shares Outstanding: 7.96M
Underwriters: Chardan Capital Markets LLC, Maxim Group LLC
Co-manager: Feltl & Co
Company Counsel: Loeb & Loeb
Manager Counsel: Reed Smith LLP
Auditor: Brightman Almagor & Co
Market Capitalization on 2/27/15: $ 48.43M
Close price on 2/27/15: $ 6.08
- Pontifax Ltd
- GE Capital
- Docor International BV
- CounterPoint Capital Partners LLC
- Undisclosed investor
- 3/26/08 $5M
- 10/21/14 n/a
Source: Data provided by Thomson Reuters.